Estrogen in obesity-associated colon cancer: Friend or foe? Protecting postmenopausal women but promoting late-stage colon cancer

Cancer Causes and Control

Volumn 23, Issue 11, 2012, Pages 1767-1773

  Chen, Jiezhong ^a   Iverson, Don ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

ER alpha; ER beta; Obesity associated colon cancer

Indexed keywords

ADIPONECTIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; INSULIN; INTERLEUKIN 17; INTERLEUKIN 6; LEPTIN; NATURAL PRODUCT; RALOXIFENE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CANCER CELL; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CANCER THERAPY; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; HUMAN; INTESTINE CELL; NONHUMAN; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

COLONIC NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HUMANS; INCIDENCE; OBESITY;

EID: 84867986644     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-0066-z     Document Type: Review

References (93)

1. Renehan AG et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569-578 (Pubitemid 351232031)
2. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4(8):579-591 (Pubitemid 39025053)
3. Gislette T, Chen J (2010) The possible role of IL-17 in obesityassociated cancer. Sci World J 10:2265-2271
4. Renehan AG et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and metaregression analysis. Lancet 363(9418):1346-1353 (Pubitemid 38529873)
5. Chen J et al (2011) Insulin decreases therapeutic efficacy in colon cancer cell line HT29 via the activation of the PI3 K/Akt pathway. Curr Drug Discov Technol 8(2):119-125
6. Paz-Filho G et al (2011) Associations between adipokines and obesity-related cancer. Front Biosci 16:1634-1650
7. Renehan A, Dive C (2011) Obesity, insulin and chemoresistance in colon cancer. J Gastrointest Oncol 2(1):8-10
8. Chen J et al (2011) Insulin caused drug resistance to oxaliplatin in colon cancer cell HT29. J Gastrointest Oncol 2:27-33
9. Chen J (2011) Multiple signal pathways in obesity-associated cancer. Obes Rev 12(12):1063-1070
10. Huang XF, Chen J (2009) Obesity, the PI3 K/Akt signal pathway and colon cancer. Obes Rev 10(6):610-616
11. Chen J (2012) Targeted therapy of obesity-associated colon cancer. Transl Gastrointest Cancer 1(1):44-57
12. Murphy TK et al (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152(9): 847-854
13. Ben Q et al (2012) Body mass index increases risk for colorectal adenomas based onmeta-analysis.Gastroenterology 142(4):762-772
14. Pischon T et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98(13):920-931 (Pubitemid 44018922)
15. Kim BC et al (2012) Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control 23(5):727-735
16. Terry PD, Miller AB, Rohan TE (2002) Obesity and colorectal cancer risk in women. Gut 51(2):191-194 (Pubitemid 34791445)
17. Hou L et al (2006) Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier. Eur J Cancer 42(1):84-90 (Pubitemid 41814536)
18. Slattery ML et al (2001) Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 61(1):126-130 (Pubitemid 32095709)
19. Sikalidis AK, Varamini B (2011) Roles of hormones and signalling molecules in describing the relationship between obesity and colon cancer. Pathol Oncol Res 17(4):785-790
20. Gunter MJ et al (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 68(1):329-337 (Pubitemid 351380136)
21. English MA et al (1999) Loss of estrogen inactivation in colonic cancer. J Clin Endocrinol Metab 84(6):2080-2085 (Pubitemid 30647037)
22. Lin J et al (2004) Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control 15(6):581-589 (Pubitemid 39070076)
23. Di Domenico M et al (1996) Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56(19):4516-4521 (Pubitemid 26330464)
24. Narayan S et al (1992) Estradiol is trophic for colon cancer in mice: effect on ornithine decarboxylase and c-myc messenger RNA. Gastroenterology 103(6):1823-1832
25. Rondini EA et al (2011) Energy balance modulates colon tumour growth: interactive roles of insulin and estrogen. Mol Carcinog 50(5):370-382
26. Enmark E et al (1997) Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82(12):4258-4265 (Pubitemid 27525550)
27. Menasce LP et al (1993) Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 17(1):263-265 (Pubitemid 23205095)
28. Motylewska E, Stasikowska O, Melen-Mucha G (2009) The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line. Cancer Lett 276(1):68-73
29. Greene GL et al (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231(4742): 1150-1154 (Pubitemid 16016313)
30. Cho MA et al (2007) Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis. J Endocrinol 195(2):255-263 (Pubitemid 350143105)
31. Chow SK, Chan JY, Fung KP (2004) Suppression of cell proliferation and regulation of estrogen receptor alpha signalling pathway by arsenic trioxide on human breast cancer MCF-7 cells. J Endocrinol 182(2):325-337 (Pubitemid 39199016)
32. Nilsson S et al (2001) Mechanisms of estrogen action. Physiol Rev 81(4):1535-1565 (Pubitemid 32951806)
33. de Batistuzzo Medeiros SR (1997) Functional interactions between the estrogen receptor and the transcription activator Sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 io promoter. J Biol Chem 272(29):18250-18260 (Pubitemid 27306414)
34. Porter W et al (1997) Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11(11):1569-1580 (Pubitemid 27435406)
35. Qin C, Singh P, Safe S (1999) Transcriptional activation of insulin-like growth factor-binding protein-4 by 17beta-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology 140(6):2501-2508 (Pubitemid 32245126)
36. Webb P et al (1999) The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13(10): 1672-1685 (Pubitemid 30645272)
37. Wang C et al (2011) Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Mol Endocrinol 25(9):1527-1538
38. Bjornstrom L, Sjoberg M (2005) Mechanisms of estrogen receptor signalling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19(4):833-842 (Pubitemid 40397050)
39. Hewitt SC et al (2005) Global uterine genomics in vivo: microarray evaluation of the estrogen receptor alpha-growth factor cross-talk mechanism. Mol Endocrinol 19(3):657-668 (Pubitemid 40349438)
40. Simoncini T et al (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407(6803):538-541
41. Le Romancer M et al (2008) Regulation of estrogen rapid signalling through arginine methylation by PRMT1. Mol Cell 31(2): 212-221 (Pubitemid 352005820)
42. Yang Z, Barnes CJ, Kumar R (2004) Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells. Clin Cancer Res 10(11):3621-3628 (Pubitemid 38697595)
43. Duan R et al (2001) Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1. J Biol Chem 276(15):11590-11598
44. Acconcia F et al (2005) Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signalling. J Cell Physiol 203(1):193-201 (Pubitemid 40330938)
45. La Rosa P et al (2011) 17beta-Estradiol-induced cell proliferation requires estrogen receptor (ER) alpha monoubiquitination. Cell Signal 23(7):1128-1135
46. Marino M, Acconcia F, Trentalance A (2003) Biphasic estradiolinduced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell 14(6):2583-2591 (Pubitemid 36724344)
47. Song RX et al (2004) The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci USA 101(7):2076-2081 (Pubitemid 38229017)
48. Zhang Z et al (2004) The role of adapter protein Shc in estrogen non-genomic action. Steroids 69(8-9):523-529 (Pubitemid 39013482)
49. Fernando RI, Wimalasena J (2004) Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signalling through ERK and Akt. Mol Biol Cell 15(7):3266-3284 (Pubitemid 38850122)
50. Marino M et al (2002) Distinct nongenomic signal transduction pathways controlled by 17beta-estradiol regulate DNA synthesis and cyclin D(1) gene transcription in HepG2 cells. Mol Biol Cell 13(10):3720-3729 (Pubitemid 35191387)
51. Bredfeldt TG et al (2010) Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signalling to PI3 K/AKT. Mol Endocrinol 24(5):993-1006
52. Gustafsson JA (1999) Estrogen receptor beta\a new dimension in estrogen mechanism of action. J Endocrinol 163(3):379-383
53. Kuiper GG et al (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93(12):5925-5930 (Pubitemid 26190778)
54. Zhao C, Dahlman-Wright K, Gustafsson JA (2010) Estrogen signalling via estrogen receptor {beta}. J Biol Chem 285(51): 39575-39579
55. Galluzzo P et al (2007) Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer 14(1):153-167 (Pubitemid 47526997)
56. Weige CC, Allred KF, Allred CD (2009) Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res 69(23):9118-9124
57. Edvardsson K et al (2011) Estrogen receptor beta induces antiinflammatory and antitumorigenic networks in colon cancer cells. Mol Endocrinol 25(6):969-979
58. Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824):37-40 (Pubitemid 32225829)
59. Dhanasekaran DN, Johnson GL (2007) MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene 26(22): 3097-3099 (Pubitemid 46763009)
60. Cuenda A, Rousseau S (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773(8):1358-1375 (Pubitemid 47125981)
61. Porras A et al (2004) P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15(2):922-933 (Pubitemid 38146504)
62. Hui L et al (2007) p38alpha: a suppressor of cell proliferation and tumorigenesis. Cell Cycle 6(20):2429-2433 (Pubitemid 350058657)
63. Shimada K et al (2003) Roles of p38-and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 24(6):1067-1075 (Pubitemid 36827258)
64. Hui L et al (2007) p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39(6):741-749 (Pubitemid 46848584)
65. Iwasa H, Han J, Ishikawa F (2003) Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8(2):131-144 (Pubitemid 36511698)
66. Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK (2004) Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res 64(20):7336-7345 (Pubitemid 39372072)
67. Feng Y, Wen J, Chang CC (2009) p38 Mitogen-activated protein kinase and hematologic malignancies. Arch Pathol Lab Med 133(11):1850-1856
68. Gompel A et al (2004) Steroidal hormones and proliferation, differentiation and apoptosis in breast cells. Maturitas 49(1):16-24 (Pubitemid 39209367)
69. Lin JH et al (2012) Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression. Cancer Res 72(12):3020-3028
70. Tanaka Y et al (2008) Medroxyprogesterone acetate inhibits proliferation of colon cancer cell lines by modulating cell cyclerelated protein expression. Menopause 15(3):442-453 (Pubitemid 351656748)
71. Gizard F et al (2005) Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclindependent kinase inhibitor p27Kip1 gene. FEBS Lett 579(25): 5535-5541 (Pubitemid 41455627)
72. Konstantinopoulos PA et al (2003) Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39(9):1251-1258 (Pubitemid 36579196)
73. Qiu Y et al (2002) Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 174(3):369-377
74. Jassam N et al (2005) Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep 14(1):17-21
75. Fang YJ et al (2010) Prognostic impact of ERbeta and MMP7 expression on overall survival in colon cancer. Tumour Biol 31(6):651-658
76. Wong NA et al (2005) ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 207(1):53-60 (Pubitemid 41200714)
77. Wu AH et al (2010) Hormone therapy, DNA methylation and colon cancer. Carcinogenesis 31(6):1060-1067
78. Lin KJ et al (2012) The effect of estrogen vs. combined estrogenprogestogen therapy on the risk of colorectal cancer. Int J Cancer 130(2):419-430
79. Hiraoka S et al (2010) Methylation status of normal background mucosa is correlated with occurrence and development of neoplasia in the distal colon. Hum Pathol 41(1):38-47
80. Anghel A et al (2010) Estrogen receptor alpha polymorphisms and the risk of malignancies. Pathol Oncol Res 16(4):485-496
81. Worthley DL et al (2010) DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 29(11):1653-1662
82. Honma et al (2012) Estrogen receptor-beta gene polymorphism and colorectal cancer risk: effect modified by body mass index and isoflavone intake. Int J Cancer
83. Saleiro et al (2012) Estrogen receptor-beta protects against colitis-associated neoplasia in mice. Int J Cancer
84. Gallo D et al (2012) Estrogen receptor beta in cancer: an attractive target for therapy. Curr Pharm Des 18(19):2734-2757
85. Yi KW et al (2008) Role of estrogen receptor-alpha and-beta in regulating leptin expression in 3T3-L1 adipocytes. Obes (Silver Spring) 16(11):2393-2399
86. Nejati-Koshki et al (2012) Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors. Cytotechnology
87. Mendoza RA et al (2011) Interactions between IGF-I, estrogen receptor-alpha (ERalpha), and ERbeta in regulating growth/apoptosis of MCF-7 human breast cancer cells. J Endocrinol 208(1):1-9
88. Harris DM et al (2005) Phytoestrogens induce differential estrogen receptor alpha-or Beta-mediated responses in transfected breast cancer cells. Exp Biol Med (Maywood) 230(8):558-568 (Pubitemid 41233155)
89. Schleipen B et al (2011) ERbeta-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine. Carcinogenesis 32(11):1675-1683
90. Bielecki A et al (2011) Estrogen receptor-beta mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutr Cancer 63(1):139-150
91. Cotterchio M et al (2006) Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136(12):3046-3053 (Pubitemid 44878571)
92. Yang G et al (2009) Prospective cohort study of soy food intake and colorectal cancer risk in women. Am J Clin Nutr 89(2):577-583
93. Tu Z et al (2012) Estrogen receptor beta potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells. J Cancer Res Clin Oncol 138(7):1091-1103